Related Experiment Video
Updated: Jul 12, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Nonsteroidal anti-inflammatory drug-induced hepatotoxicity
Guruprasad P Aithal1, Christopher P Day
1Queen's Medical Centre, University Hospital, D Floor, South Block, Nottingham, NG7 2UH, UK. guru.aithal@nuh.nhs.uk
Abstract:
Nonsteroidal anti-inflammatory drugs are among the most common drugs associated with drug-induced liver injury, with an estimated incidence of between 3 and 23 per 100,000 patient years. Nimesulide, sulindac, and diclofenac seem to be associated with the highest risk and the only risk factor consistently identified is the concomitant use of other hepatotoxic drugs. Diclofenac-induced liver injury is a paradigm for drug-related hepatotoxicity. Recent studies suggest that genetic factors favoring the formation and accumulation of the reactive acylglucuronide metabolite of diclofenac and an enhanced immune response to the metabolite-protein adducts are associated with increased susceptibility to hepatotoxicity.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Toxicity: Allergic Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
Allergic Drug Reactions
